Blood Tests for Brain-Injury Biomarkers Could Be Used to Monitor Patients with Moderate to Severe COVID-19
Some COVID-19 patients exhibit clinical and neurochemical signs of brain injury, according to a new study which showed that finding and measuring a blood-based biomarker for brain damage proved to be possible. More...04 Aug 2021
Cepheid Developing New COVID-19 Diagnostics for Pooled Samples and Rapid Detection of SARS-Cov-2 Variants
Cepheid, Inc. (Sunnyvale, CA, USA) is collaborating with the Biomedical Advanced Research and Development Authority (BARDA; Washington, DC, USA) on rapid diagnostic testing for pooled samples to address COVID-19, detect novel and emerging coronaviruses, and increase pandemic preparedness. More...03 Aug 2021
Next Generation End-To-End Digital COVID-19 Screening Solution to Help Prevent Outbreaks
With connected point-of-care screening becoming a critical security mechanism of the post-pandemic normalcy, a new next generation end-to-end COVID-19 screening solution could help prevent future outbreaks. More...03 Aug 2021
PCR of Gargle Lavage Samples as Effective as Nasopharyngeal Swabs to Identify SARS-CoV-2 Infection, Finds Study
Twenty-six subjects from a cohort of 80 tested positive for SARS-CoV-2 via nasopharyngeal swab, and all 26 tested positive using gargle lavage (mouthwash), according to new research. More...30 Jul 2021
CerTest Launches VIASURE SARS-CoV-2 Variant II Real Time PCR Detection Kit
CerTest Biotec (Zaragoza, Spain) has launched VIASURE SARS-CoV-2 Variant II Real Time PCR Detection Kit, a real-time RT-PCR test designed for the qualitative detection of RNA from genetic mutations in the S gene (P681R, L452R and E484Q) from positive SARS-CoV-2 nasopharyngeal samples. More...30 Jul 2021
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit
New
Human Insulin CLIA
Human Insulin CLIA Kit
In Other News
Breakthrough Identification of First Saliva Activated Biosensor Molecules to Diagnose COVID-19 Paves Way for New Oral Screening Test
COVID-19 Severity Test Reads Immune System in Real Time Using Machine Learning for Predicting Severe Outcomes
Ultra-Fast, Fully Automated SARS-CoV-2 Virus Detection Test Uniquely Suited for Near Patient Testing
Less-Sensitive COVID-19 Tests Could Still Achieve Optimal Results If Enough People Are Tested
Same Nasal Swabs Used to Diagnose COVID-19 Could Also Identity Potentially Severe Cases
Eurofins Viracor Launches Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity Testing to Aid COVID-19 Treatment Decisions
Microarray-Based COVID-19 Test Analyzes Sample in Triplicate for Each Patient Swab Within Each Array For 100% Specificity
Non-Invasive COVID-19 Diagnostic System Collects Sample Droplets from Lungs and Returns Results in 10 Minutes
AACC Publishes New COVID-19 Guidelines for Clinical Laboratories
Novel T-Cell Test for SARS-CoV-2 Can Help Monitor Cellular Immunity Against COVID-19
Enzo Biochem Receives FDA EUA for Rapid Extraction Method on Proprietary Test System for Detection of SARS-CoV-2
Serum Biomarkers Enable Tracing the Progress of COVID-19 Infections
Rapid Olfactory Test Shows Potential as Screening Tool for COVID-19
New Diagnostic Test Could Detect Biological ‘Fingerprints’ of Long COVID in Blood
Artificial Intelligence (AI) Model Identifies COVID-19 Patients Using Blood Tests and Chest X-Rays
First-Ever Serology Test Built on Multiparameter Flow Cytometry Platform Differentiates Between COVID-19 Infection and Vaccination Antibodies
New Highly Sensitive Blood Test Accurately Measures Immunity Against SARS-CoV-2
Two-Minute COVID-19 Test Uses Nanosensor Technology to Detect Presence of SARS-CoV-2 Infection in Blood at POC
Global Lateral Flow Assays Market to Reach USD 11.2 Billion by 2026 Due to Robust Demand for COVID-19 Screening Tests
Lateral Flow Tests Detect COVID-19 with Similar Accuracy to Laboratory-Based PCR Tests When Used at Onset of Symptoms
Seegene Launches New Multiplex PCR Test Capable of Screening Six SARS-CoV-2 Variants
Blood Test That Quantifies Protein ACE2 and ACE2 Fragments Can Monitor SARS-CoV-2 Infection
Global COVID-19 Diagnostic Market to Reach USD 65.75 Billion by 2028
